Influence of the major histocompatibility complex on age at onset of chronic lymphoid leukaemia

International Journal of Cancer

Volumn 65, Issue 2, 1996, Pages 134-139

  Tevfik Dorak, M ^a   Machulla, Helmut K G ^b   Hentschel, Michael ^b   Mills, Ken I ^a   Langner, Jürgen ^b   Burnett, Alan K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 9044243014     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19960117)65:2<134::aid-ijc2>3.3.co;2-m     Document Type: Article

References (39)

1. APPLE, R.J., ERLICH, H.A., KLITZ, W., MANOS, M.M., BECKER, T.M. and WHEELER, C.M., HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genet., 6, 157-162 (1994).
2. BORTIN, M.M., D'AMARO, J., BACH, F.H., RIMM, A.A. and VAN ROOD, J.J., HLA association with leukemia. Blood, 70, 227-232 (1987).
3. BOYSE, E.A., OLD, L.J. and STOCKERT, E., The relation of linkage group IX to leukemogenesis in the mouse. In. P. Emmelot and P. Bentvelzen (eds.), RNA viruses and host genome in oncogenesis, pp. 171-185, North-Holland Publishing, Amsterdam (1972).
4. CARUSO, C., LO CAMPO, P., BOTINDARI, C. and MODICA, M.A., HLA antigens in Sicilian patients affected by chronic myelogenous leukaemia. J. Immunogenet., 14, 295-299 (1987).
5. CHESEBRO, B., Influence of the major histocompatibility complex (H-2) on oncornavirus-jnduced neoplasia in mice. In: H.E. Kaiser (ed.), Neoplasms - comparative pathology of growth in animals, plants, and man, pp. 475-482, Williams and Wilkins, Baltimore (1981).
6. CUTTNER, J., SKERRETT, D., ROSINA, O., TROY, K.M., WALLENSTEIN, S. and SPIVACK, M., Increased incidence of HLA antigen B35 in patients with chronic lymphocytic leukemia. Leukemia Res., 18, 565-567 (1994).
7. DORAK, M.T. and BURNETT, A.K., Major histocompatibility complex, t-complex, and leukemia. Cancer Causes Control, 3, 273-282 (1992).
8. DORAK, M.T. and BURNETT, A.K., Molecular mimicry of an HLA-DR53 epitope by viruses. Immunol. Today, 15, 138-139 (1994).
9. DORAK, M.T., CHALMERS, E.A., GAFFNEY, D., WILSON, D.W.L., GALBRAITH, I., HENDERSON, N., WORWOOD, M., MILLS, K.I. and BURNETT, A.K., Human major histocompatibility complex contains several leukemia susceptibility genes. Leukemia Lymph., 12, 211-222 (1994a).
10. DORAK, M.T., MILLS, K.I., GAFFNEY, D., WILSON, D.W.L., GALBRAITH, I., HENDERSON, N. and BURNETT, A.K., Homozygous MHC genotypes and longevity. Human Hered , 44, 271-278 (1994b).
11. DORAK, M.T., OWEN, G., GALBRAITH, I., HENDERSON, N., WEBB, D., MILLS, K.I., DARKE, C. and BURNETT, A.K., Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia. Leukemia, 9, 875-878 (1995).
12. DYER, P.A., RIDWAY, J.C. and FLANAGAN, N.G., HLA-A, B and DR antigens in chronic lymphocytic leukaemia. Dis. Markers, 4, 231-237 (1986).
13. FARALDO, M.J., DUX, A., MUHLBOCK, O. and HART, G., Histocompatibility genes (the H-2 complex) and susceptibility to spontaneous lung tumors in mice. Immunogenetics, 9, 383-404 (1979).
14. FRASER, P.A., STERN, S., LARSON, M.G., MARCUS-BAGLEY, D., AWDEH, Z., GLASS, D.N. and ALPER, C.A., HLA extended haplotypes in childhood and adult unset HLA-DR4-associated arthropathies. Tiss. Antigens, 35, 56-59 (1990).
15. ISOMÄKI, H.A., HAKULINEN, T. and JOUTSENLAHTI, U., Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J. chron. Dis., 31, 691-696 (1978).
16. KILPATRICK, D.C., DEWAR, A.E., STOCKDILL, G., MAGINNIS, M., JORDAN, A., NEILL, G.W , GELSTHORPE, K. and YAP, P.L., Histocompatibility antigen frequencies in patients with chronic lymphocytic leukaemia: possible identification of a subgroup with relatively benign disease. Scand. J. Haematol , 33, 391-396 (1984).
17. KLEIN, J., Genetic control of virus susceptibility. In: Biology of the mouse histocompatibility-2 complex, pp. 389-410, Springer, Berlin (1975).
18. KLITZ, W., ALDRICH, C.L., FILDES, N., HORNING, S.J. and BEGOVICH, A.B., Localization of predisposition to Hodgkin disease in the HLA class II region. Amer. J. hum. Genet., 54, 497-505 (1994).
19. LILLY, F., BOYSE, E.A. and OLD, L.J., Genetic basis of susceptibility to viral leukaemogenesis. Lancet, ii, 1207-1209 (1964).
20. LILLY, F. and PINCUS, T., Genetic control of murine leukemogenesis. Advanc. Cancer Res., 17, 231-277 (1973).
21. LONAI, P., KATZ, E. and HARAN-GHERA, N., Role of the major histocompatibility complex in resistance to viral leukemia: its effect on the preleukemic stage of leukemogenesis. Springer Semin. Immunopathol., 4, 373-396 (1982).
22. MATSUYAMA, T., SCHWENZER, J., SILVER, J. and WINCHESTER, R., Structural relationships between the DRβ1 and DRβ2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity. J. Immunol., 137, 934-940 (1986).
23. MCCLUSKEY, J., KAY, P.H., DAWKINS, R.L., KOMORI, K., CHRISTIANSEN, F.T. and MCCANN, V.J., Association of specific MHC supratypes with rheumatoid arthritis and insulin-dependent diabetes mellitus. Dis. Markers, 1, 197-212 (1983).
24. MIYAZAWA, M., NISHIO, J., WEHRLY, K. and CHESEBRO, B., Influence of MHC genes on spontaneous recovery from Friend retrovirus-induced leukemia. J. Immunol., 148, 644-647 (1992).
25. NUNEZ-ROLDAN, A., SZER, I., TOGUCHI, T., CUTTNER, J. and WINCHESTER, R., Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia: recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR series. J. exp. Med., 156, 1872-1877 (1982).
26. OLLIER, W., CARTHY, D., CUTBUSH, S., OKOYE, R., AWAD, J., FIELDER, A., SILMAN, A. and FESTENSTEIN, H., HLA-DR associated Dw types in rheumatoid arthritis. Tiss. Antigens, 33, 30-37 (1989).
27. OOMEN, L.C.J.M., VAN DER VALK, M.A., HART, A.A.M., DEMANT, P. and EMMELOT, P., Influence of mouse major histocompatibility complex (H-2) on N-ethyl-N-nitrosourea-induced tumor formation in various organs. Cancer Res., 48, 6634-6641 (1988).
28. k antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities. Tiss. Antigens, 19, 289-300 (1982).
29. POLLACK, M.S., Genetic and technical aspects of the HLA system and its possible role in human malignancy. Cancer Invest., 2, 399-411 (1984).
30. PRAZAK, J. and HERMANSKA, Z., Study of HLA antigens in patients with Hodgkin's disease. Europ. J. Haematol., 43, 50-53 (1989).
31. PRIOR, P., Cancer and rheumatoid arthritis: epidemiologic considerations. Amer. J. Med., 78(suppl. 1A), 15-21 (1985).
32. RICHTER, K.V., FISCHER, G., MENZEL, G.R., LANGFELD, M., AIGTE, H., RUCKWARTH, G. and FREIER, G., HL-A Antigene und Disposition fur hämatologische maligne Erkrankungen. Haematologia, 7, 203-209 (1973).
33. SEREMETIS, S., CUTTNER, J and WINCHESTER, R., Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope. J. clin. Invest., 76, 1391-1397 (1985).
34. TIWARI, J.L. and TERASAKI, P.I., HLA and disease associations. Springer, New York (1985).
35. VAN EIJK, M.J.T., STEWART-HAYNES, J.A., BEEVER, J.E., FERNANDO, R.L. and LEWIN, H.A., Development of persistent lymphocytosis in cattle is closely associated with DRB2. Immunogenetics, 37, 64-68 (1992).
36. VASMEL, W.L.E., ZIJLSTRA, M., RADASKIEWICZ, T., LEUPERS, C.J.M., DE GOEDE, R.E.Y. and MELIEF, C.J.M., Major histocompatibility complex class-II-regulated immunity to murine leukemia virus protects against early T- but not late B-cell lymphomas. J. Virol., 62, 3156-3166 (1988).
37. WILTON, A.N., CHRISTIANSEN, F.T. and DAWKINS, R.L., Supratype matching improves renal transplant survival. Transplant. Proc., 17, 2211-2216 (1985).
38. WINCHESTER, R., The molecular basis of susceptibility to rheumatoid arthritis. Advanc. Immunol., 56, 389-466 (1994).
39. ZIJLSTRA, M. and MELIEF, C.J.M., Virology, genetics and immunology of murine lymphomagenesis. Biochim. biophys. Acta, 865, 197-231 (1986).